| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |